2型糖尿病的持续时间是否影响有氧运动干预措施的有效性:INTENSITY研究的结果
Amy M Thomson1,2, Brittany V Rioux1,2, Travis J Hrubeniuk3,4
1Cardiometabolic Exercise & Lifestyle Laboratory, Fredericton, Canada.
PloS one
|June 6, 2024
概括
有氧运动对短期和长期的2型糖尿病 (T2DM) 都有好处. 长期T2DM患者的身体组成变化与改善的血糖相关.
科学领域:
- 运动生理学 运动生理学
- 代谢性疾病研究研究.
- 临床干预研究临床干预研究
背景情况:
- 2型糖尿病 (T2DM) 持续时间较长与并发症和死亡率的增加有关.
- 对于T2DM持续时间对有氧运动干预疗效的影响尚不清楚.
研究的目的:
- 比较有氧运动对身体构成,心肺呼吸能力和血糖的影响,在短时间和长时间的T2DM中.
- 根据T2DM持续时间调查这些变化与血糖之间的关联.
主要方法:
- 对INTENSITY研究的二次分析 (NCT03787836).
- 34名患有T2DM的成年人进行了28周的中度至强度有氧运动 (每周150分钟).
- 参与者分为短期 (<5年) 和长期 (≥5年) T2DM组. 测量HbA1c,身体组成 (BodPod) 和VO2峰值.
主要成果:
- 两组都显示脂肪质量和HbA1c的减少;长期治疗组也增加了无脂肪质量.
- 短期和长期T2DM组之间的结果没有显著差异.
- 在长期的T2DM中,脂肪质量和体脂百分比的变化与HbA1c的改善相关.
结论:
- T2DM持续时间没有显著改变28周有氧运动干预措施的整体有效性.
- 身体组成的改善与较长T2DM持续时间的个体中更好的血糖控制有关.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications
523
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523
Diabetes: Management and Pharmacotherapy
260
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
260
Insulin: Dosing Regimen and Adverse Effects
166
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
166


